Carrefour continued to sell off key assets in Southeast Asia with the divestment of its 60 percent stake in its Indonesian supermarket operations to local partner CT Corp for 525 million euros ($673 million). Clifford Chance and Hadiputranto, Hadinoto & Partners advised the seller, while Ashurst advised CT Corp.

Carrefour, the world’s second-largest retailer after Wal-Mart Corp, has been scaling back its presence in Asia as part of a plan to cut debt and refocus on core operations, according to Reuters. Assisted by Clifford Chance and Wong & Partners, Carrefour sold its Malaysian operations last month to Aeon, Japan’s largest supermarket operator. It has also said it would close its two stores in Singapore.

CT Corp, a conglomerate with banking and media interests, previously owned a 40 percent stake in the joint venture. In July, Reuters reported that CT Corp was in talks to acquire the rest of the supermarket chain. Under the deal, the company will retain exclusive rights to use the Carrefour brand in Indonesia under a licence agreement with the French retailer.

Clifford Chance’s Hong Kong-based partners Emma Davies and Peter Kilner led on the deal, assisted by partner Mathieu Remy in the firm’s Paris office. Hadiputranto, Hadinoto & Partners advised Carrefour on Indonesian law.

The deal is expected to close in January next year, subject to the approval of the Indonesian antitrust authorities.

Kanishk Verghese is North Asia journalist at ALB. Follow us on Twitter: @ALB_Magazine.

Other related stories:

Related Articles

CC, Paul Hastings lead on CR Beverages’ HK IPO

by Charlie Wu 吴卓言 |

Clifford Chance and Jingtian & Gongcheng are advising China Resources Beverages, the beverage division of the state-owned China Resources Enterprise, on its upcoming Hong Kong IPO, which is expected to raise up to $1 billion. Paul Hastings and Zhong Lun Law Firm are acting for the joint sponsors.

Haiwen, CC advise on China TCM's $2 bln take-private deal

Sinopharm Group, an investment consortium led by Sinopharm Group, and China Traditional Chinese Medicine Holdings (China TCM) recently announced a take-private deal for the Hong Kong-listed China TCM through a scheme of arrangement.

CC, Davis Polk act on ChaPanda’s $330 mln Hong Kong IPO

by Charlie Wu 吴卓言 |

Davis Polk & Wardwell and Jingtian & Gongcheng have advised Sichuan Baicha Baidao, a Chinese low-priced tea chain also known as ChaPanda, on its $330 million IPO on the Hong Kong Stock Exchange, with Clifford Chance and King & Wood Mallesons acting for the sponsor CICC and underwriters.